Daily Archives: September 28, 2017

What is Spinraza? SPINRAZA is the first and only FDA-approved treatment for spinal muscular atrophy (SMA). In laboratory tests and animal studies, it was shown to increase full-length survival motor neuron (SMN) protein by targeting the process through which it … Continue reading →